AVCN — Avicanna Income Statement
0.000.00%
Last trade - 00:00
- CA$41.97m
- CA$51.27m
- CA$16.79m
- 27
- 22
- 73
- 35
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.168 | 1.57 | 3.27 | 4.05 | 16.8 |
Cost of Revenue | |||||
Gross Profit | 0.065 | 1.06 | 1.37 | 1.87 | 7.62 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 23.4 | 33.3 | 18.8 | 17.1 | 25.2 |
Operating Profit | -23.2 | -31.7 | -15.6 | -13.1 | -8.38 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -23.2 | -35 | -16.8 | -14.7 | -8.74 |
Provision for Income Taxes | |||||
Net Income After Taxes | -22.2 | -32.9 | -16.8 | -14.7 | -8.74 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -21.1 | -32.9 | -16.8 | -14.7 | -8.74 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.1 | -32.9 | -16.8 | -14.7 | -8.74 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.05 | -0.784 | -0.365 | -0.192 | -0.092 |